Supply Chain news and information

Vital Signs
Shutdown won't stop FDA advisory meetings

By Jaimy Lee | October 07, 2013

The government shutdown isn't stopping Food and Drug Administration advisory committee meetings scheduled this month, according to drug and device manufacturers.
FULL STORY »

Comment

Information
Justices seek White House views in medical device case

By Reuters | October 07, 2013

The Supreme Court on Monday sought the legal views of the Obama administration in a medical device manufacturer's appeal of a ruling that the company can be sued by a man who was left paralyzed after using one of its products.
FULL STORY »

Comment

Information
Pharmaceutical firms paid to attend meetings of panel that advises FDA

By Washington Post | October 07, 2013

A scientific panel that shaped the government's policy for testing the safety and effectiveness of painkillers was funded by major pharmaceutical firms seeking to affect the thinking of the FDA.
FULL STORY »

Comment

Information
Texas turned to compounding pharmacy for execution drugs

By Michael Graczyk / Associated Press | October 03, 2013

The nation's most active death-penalty state has turned to a compounding pharmacy to replace its expired execution drugs, according to documents released Wednesday, weeks after Texas prison officials declined to say how they obtained the drugs amid a nationwide shortage.
FULL STORY »

Comment

Vital Signs
PhRMA sues to stop 340B pricing for orphan drugs

By Jaimy Lee | October 02, 2013

PhRMA has sued to block implementation of a rule that lets providers in the 340B drug discount program buy orphan drugs at reduced prices if the drugs are used to treat non-orphan conditions.
FULL STORY »

Comment

Advertisement | View Media Kit

Information
Merck to cut 8,500 more jobs

By Tom Murphy / Associated Press | October 01, 2013

Merck & Co. plans to cut another 8,500 jobs as the drugmaker continues its struggle with competition from cheaper generic medications that have squeezed the pharmaceutical industry for several quarters now.
FULL STORY »

Comment

Information
FDA approves first pre-surgical breast cancer drug

By Associated Press | September 30, 2013

A biotech drug from Roche has become the first medicine approved to treat breast cancer before surgery, offering an earlier approach against one of the deadliest forms of the disease.
FULL STORY »

Comment

Magazine
Compounding changes | Litigation, legislation among fallout from outbreak

By Jaimy Lee | September 28, 2013 | Print Magazine

A year ago, few people outside of the pharmacy sector knew much about drug compounding. Now the industry is at the center of legal and regulatory action.
FULL STORY »

Comment

News
Premier goes public in IPO valued at $760 million

By Beth Kutscher | September 26, 2013 | Basic Web

Premier, one of the nation's largest group purchasing organizations, went public today with an initial stock offering valued at $760.1 million.
FULL STORY »

Comment

News
Bill makes compounders' participation in oversight voluntary

By Jaimy Lee | September 26, 2013 | Basic Web

A bill in Congress aimed at strengthening oversight of compounding pharmacies would make drug compounders' participation in a new regulatory category voluntary rather than mandatory.
FULL STORY »

Comment